Insider Transactions in Q4 2025 at Immunome Inc. (IMNM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2025
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
4,729
+0.71%
|
$99,309
$21.15 P/Share
|
|
Dec 22
2025
|
Isaac Barchas |
SELL
Open market or private sale
|
Indirect |
383,200
-7.98%
|
$8,430,400
$22.03 P/Share
|
|
Dec 19
2025
|
Jack Higgins Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
3,000
+50.0%
|
-
|
|
Dec 19
2025
|
Jack Higgins Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
3,000
-2.52%
|
-
|
|
Dec 19
2025
|
Clay B Siegall President and CEO |
SELL
Bona fide gift
|
Direct |
200,000
-23.24%
|
-
|
|
Dec 19
2025
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
7,278
+0.84%
|
$145,560
$20.48 P/Share
|
|
Dec 19
2025
|
Philip Tsai Chief Technical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+18.76%
|
$200,000
$20.49 P/Share
|
|
Dec 18
2025
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
46,511
+5.17%
|
$976,731
$21.5 P/Share
|